MYLAN 5340 MYLAN 5340 Pill: blue & pink , capsule/oblong, 23mm
The pill with imprint MYLAN 5340 MYLAN 5340 (Blue & Pink, Capsule/Oblong1) has been identified as Diltiazem Hydrochloride Extended-Release (XR) 240 mg and is used for Atrial Fibrillation, Atrial Flutter, Heart Failure, High Blood Pressure, and Angina Pectoris Prophylaxis. It belongs to the drug classes calcium channel blockers, group IV antiarrhythmics and is not a controlled substance.
Images for MYLAN 5340 MYLAN 5340
Diltiazem Hydrochloride Extended-Release (XR)
- Imprint
- MYLAN 5340 MYLAN 5340
- Strength
- 240 mg
- Color
- Blue & Pink
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
ammonia,
dibutyl sebacate,
magnesium stearate,
maltodextrin,
microcrystalline cellulose,
oleic acid,
silicon dioxide,
sodium lauryl sulfate,
FD&C Blue No. 1,
FD&C Red No. 40,
titanium dioxide,
ferrosoferric oxide,
D&C Yellow No. 10,
FD&C Blue No. 2,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-5340 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0949 (Discontinued) | UDL Laboratories Inc. |
See also:
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (192)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
Other brands
Cardizem, Cartia XT, Dilt-XR, Matzim LA, ... +5 more
Professional resources
- Diltiazem Hydrochloride monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Dilt-XR, Tiadylt ER, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.